ZELDA trial

The ZELDA trial is a clinical study that tested a new minimally invasive procedure to treat excess tissue growth around the blades of the heart's mitral valve (called mitral regurgitation). Using a device inserted through the blood vessels, the procedure aims to improve valve function without open-heart surgery. The trial evaluated the safety and effectiveness of this approach, comparing results to traditional treatments. If successful, ZELDA could offer a less risky, more convenient option for patients with mitral valve problems, potentially improving quality of life and reducing recovery times.